Other downstream targets measured (Akt, NF-κB, and b-Raf) in tumours from combination-treated mice were all significantly decreased in control, whereas p-Akt and NF-κB were also decreased in control and EGCG (Figure 3A and B). This evidence concerns the gene AKT1 and neoplasm.